AP
ABIONYX Pharma
Biopharmaceutical company developing innovative therapies for sepsis and intensive care.
About
ABIONYX Pharma is a next-generation biopharmaceutical company focused on developing innovative therapies for sepsis and intensive care. Their approach is based on a proprietary technology platform utilizing apoA-I.
Technology stack
detected 2026-06-16Est. monthly stack spend~$180/mo
Email
Microsoft 365
Hosting
self_managed
Stack
jQuery
Analytics
Google Analytics 4
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does ABIONYX Pharma do?
ABIONYX Pharma is a next-generation biopharmaceutical company focused on developing innovative therapies for sepsis and intensive care. Their approach is based on a proprietary technology platform utilizing apoA-I.
How much funding has ABIONYX Pharma raised?
ABIONYX Pharma has raised a total of $159M in funding. The most recent round on record is Undisclosed.
Where is ABIONYX Pharma headquartered?
ABIONYX Pharma is headquartered in Toulouse, France.
When was ABIONYX Pharma founded?
ABIONYX Pharma was founded in 2015.
What industry does ABIONYX Pharma operate in?
ABIONYX Pharma operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, MedTech, HealthTech.